UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Medipost wins patent for Cartistem in Europe
Medipost said Wednesday that it has acquired patents on its core production...
by Lee Han-soo
|
2017-12-06 13:15
라인
MGmed emerges as largest shareholder of UK bio venture
MGmed said it has emerged as the largest stakeholder of Oxford Vacmedix (OV...
by Marian Chu
|
2017-12-06 13:00
라인
Novartis Korea faces tax investigation
The National Tax Service launched a tax investigation into Novartis Korea o...
by Nam Doo-hyun
|
2017-12-06 10:55
라인
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun
|
2017-12-06 09:30
라인
Pfizer Korea wins pneumonia vaccine patent dispute with SK Chemicals
The Patent Court of Korea Wednesday decided to uphold Pfizer Korea’s patent...
by Marian Chu
|
2017-12-05 18:16
라인
Korean newborns expected to live 82 years on average: report
Newborns in South Korea are expected to live an average of 82.4 years, with...
by Marian Chu
|
2017-12-05 16:24
라인
Daewoong denies defeat in suit against Korea United
Daewoong Pharmaceutical said Tuesday that the recent dismissal of the paten...
by Lee Han-soo
|
2017-12-05 16:13
라인
Industry groups to support AI-based new drugs
The Korea Pharmaceutical and Bio-pharma Manufacturers’ Association (KPBMA) ...
by So Jae-hyeon
|
2017-12-05 16:13
라인
8 out of 10 nurses overwork; only 2 request extra pay
Eight out of 10 nurses overwork in three shifts per day but only 20 percent...
by Lee Min-ju
|
2017-12-05 16:02
라인
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo
|
2017-12-05 15:40
라인
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun
|
2017-12-05 14:38
라인
Koreans still favor people with type O blood, dislike type AB: survey
While some Koreans discuss blood types to break the ice, many unconsciously...
by Marian Chu
|
2017-12-05 11:36
라인
Government cancels approval for antidepressant Valdoxan
The Ministry of Food and Drug Safety said Tuesday it has canceled the drug ...
by Lee Hye-seon
|
2017-12-05 11:09
라인
Access Bio signs accord to supply malaria kit
Access Bio said Tuesday that it has signed an agreement with Chemonics and ...
by Lee Han-soo
|
2017-12-05 10:52
라인
Hallym vows to reform abusive work culture for nurses
Hallym University Medical Center said Monday it would improve its organizat...
by Marian Chu
|
2017-12-04 18:07
라인
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo
|
2017-12-04 16:17
라인
Medical supplies trade with China turn to black in 2017
Korea’s exports of medical and pharmaceutical products to China increased t...
by Nam Doo-hyun
|
2017-12-04 16:09
라인
Multinational drugmakers sweep local sales in Q3
Multinational pharmaceutical companies have swept the local sales in the th...
by So Jae-hyeon
|
2017-12-04 16:08
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun
|
2017-12-04 15:02
라인
SNUBH first to prove non-invasive test works for glaucoma patients
Researchers at Seoul National University Bundang Hospital (SNUBH) have prov...
by Marian Chu
|
2017-12-04 14:58
-
이전
261
262
263
264
265
266
267
268
269
270
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top